Peer Review reports
From: Loss of p16 does not protect against premature ovarian insufficiency caused by alkylating agents
Original Submission | ||
---|---|---|
23 Sep 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
31 Oct 2022 | Reviewed | Reviewer Report |
14 Nov 2022 | Reviewed | Reviewer Report |
7 Jan 2023 | Author responded | Author comments - Xiuliang Dai |
Resubmission - Version 3 | ||
7 Jan 2023 | Submitted | Manuscript version 3 |
10 Jan 2023 | Author responded | Author comments - Xiuliang Dai |
Resubmission - Version 4 | ||
10 Jan 2023 | Submitted | Manuscript version 4 |
12 Jan 2023 | Author responded | Author comments - Xiuliang Dai |
Resubmission - Version 5 | ||
12 Jan 2023 | Submitted | Manuscript version 5 |
24 Jan 2023 | Reviewed | Reviewer Report |
24 Jan 2023 | Reviewed | Reviewer Report |
12 Feb 2023 | Author responded | Author comments - Xiuliang Dai |
Resubmission - Version 6 | ||
12 Feb 2023 | Submitted | Manuscript version 6 |
14 Feb 2023 | Author responded | Author comments - Xiuliang Dai |
Resubmission - Version 7 | ||
14 Feb 2023 | Submitted | Manuscript version 7 |
16 Feb 2023 | Author responded | Author comments - Xiuliang Dai |
Resubmission - Version 8 | ||
16 Feb 2023 | Submitted | Manuscript version 8 |
Publishing | ||
28 Feb 2023 | Editorially accepted | |
8 Mar 2023 | Article published | 10.1186/s12884-023-05476-x |
You can find further information about peer review here.